KEGG   Oryx dammah (scimitar-horned oryx): 120870199
Entry
120870199         CDS       T07255                                 
Symbol
CDKN1A
Name
(RefSeq) cyclin-dependent kinase inhibitor 1
  KO
K06625  cyclin-dependent kinase inhibitor 1A
Organism
oda  Oryx dammah (scimitar-horned oryx)
Pathway
oda01522  Endocrine resistance
oda01524  Platinum drug resistance
oda04012  ErbB signaling pathway
oda04066  HIF-1 signaling pathway
oda04068  FoxO signaling pathway
oda04110  Cell cycle
oda04115  p53 signaling pathway
oda04151  PI3K-Akt signaling pathway
oda04218  Cellular senescence
oda04630  JAK-STAT signaling pathway
oda04921  Oxytocin signaling pathway
oda04928  Parathyroid hormone synthesis, secretion and action
oda04934  Cushing syndrome
oda05160  Hepatitis C
oda05161  Hepatitis B
oda05163  Human cytomegalovirus infection
oda05165  Human papillomavirus infection
oda05166  Human T-cell leukemia virus 1 infection
oda05167  Kaposi sarcoma-associated herpesvirus infection
oda05169  Epstein-Barr virus infection
oda05200  Pathways in cancer
oda05202  Transcriptional misregulation in cancer
oda05203  Viral carcinogenesis
oda05205  Proteoglycans in cancer
oda05206  MicroRNAs in cancer
oda05210  Colorectal cancer
oda05211  Renal cell carcinoma
oda05212  Pancreatic cancer
oda05213  Endometrial cancer
oda05214  Glioma
oda05215  Prostate cancer
oda05216  Thyroid cancer
oda05217  Basal cell carcinoma
oda05218  Melanoma
oda05219  Bladder cancer
oda05220  Chronic myeloid leukemia
oda05222  Small cell lung cancer
oda05223  Non-small cell lung cancer
oda05224  Breast cancer
oda05225  Hepatocellular carcinoma
oda05226  Gastric cancer
Brite
KEGG Orthology (KO) [BR:oda00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04012 ErbB signaling pathway
    120870199 (CDKN1A)
   04630 JAK-STAT signaling pathway
    120870199 (CDKN1A)
   04066 HIF-1 signaling pathway
    120870199 (CDKN1A)
   04068 FoxO signaling pathway
    120870199 (CDKN1A)
   04151 PI3K-Akt signaling pathway
    120870199 (CDKN1A)
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    120870199 (CDKN1A)
   04115 p53 signaling pathway
    120870199 (CDKN1A)
   04218 Cellular senescence
    120870199 (CDKN1A)
 09150 Organismal Systems
  09152 Endocrine system
   04921 Oxytocin signaling pathway
    120870199 (CDKN1A)
   04928 Parathyroid hormone synthesis, secretion and action
    120870199 (CDKN1A)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    120870199 (CDKN1A)
   05202 Transcriptional misregulation in cancer
    120870199 (CDKN1A)
   05206 MicroRNAs in cancer
    120870199 (CDKN1A)
   05205 Proteoglycans in cancer
    120870199 (CDKN1A)
   05203 Viral carcinogenesis
    120870199 (CDKN1A)
  09162 Cancer: specific types
   05210 Colorectal cancer
    120870199 (CDKN1A)
   05212 Pancreatic cancer
    120870199 (CDKN1A)
   05225 Hepatocellular carcinoma
    120870199 (CDKN1A)
   05226 Gastric cancer
    120870199 (CDKN1A)
   05214 Glioma
    120870199 (CDKN1A)
   05216 Thyroid cancer
    120870199 (CDKN1A)
   05220 Chronic myeloid leukemia
    120870199 (CDKN1A)
   05217 Basal cell carcinoma
    120870199 (CDKN1A)
   05218 Melanoma
    120870199 (CDKN1A)
   05211 Renal cell carcinoma
    120870199 (CDKN1A)
   05219 Bladder cancer
    120870199 (CDKN1A)
   05215 Prostate cancer
    120870199 (CDKN1A)
   05213 Endometrial cancer
    120870199 (CDKN1A)
   05224 Breast cancer
    120870199 (CDKN1A)
   05222 Small cell lung cancer
    120870199 (CDKN1A)
   05223 Non-small cell lung cancer
    120870199 (CDKN1A)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    120870199 (CDKN1A)
   05161 Hepatitis B
    120870199 (CDKN1A)
   05160 Hepatitis C
    120870199 (CDKN1A)
   05163 Human cytomegalovirus infection
    120870199 (CDKN1A)
   05167 Kaposi sarcoma-associated herpesvirus infection
    120870199 (CDKN1A)
   05169 Epstein-Barr virus infection
    120870199 (CDKN1A)
   05165 Human papillomavirus infection
    120870199 (CDKN1A)
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    120870199 (CDKN1A)
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    120870199 (CDKN1A)
   01522 Endocrine resistance
    120870199 (CDKN1A)
SSDB
Motif
Pfam: CDI
Other DBs
NCBI-GeneID: 120870199
NCBI-ProteinID: XP_040105742
LinkDB
Position
Unknown
AA seq 160 aa
MSEPSRDAQILRSSKACRCLFGPVDSEQLRQDCDALMASCVQEARERWNFDFVTETPLEG
DFAWERVRGLGLPKLYLPVGPRDDLGGGKRPSPSSALLQGTSQEDHLDLSLSCTLVTRSP
ERPEGTPGGPGPSQGRKRRQTSMTDFYHSKRRLICSKRKP
NT seq 483 nt   +upstreamnt  +downstreamnt
atgtctgagccgtccagggacgctcaaatcctccgcagcagcaaggcctgccgctgcctc
tttggtccagtggacagcgagcagctgcgccaggactgcgacgccctcatggccagctgc
gtgcaggaggcccgagagcggtggaacttcgactttgtcaccgagacgccgctggagggg
gactttgcctgggagcgcgtgaggggcctcggcctgcccaagctctacctgcccgtggga
ccccgagacgacctgggagggggcaagcggccgagcccctcgtccgccctgctgcagggt
acgtctcaggaggaccacttggacctgtcgctgtcctgcacccttgtgactcgctcccct
gagcggcccgaggggacccccggtgggcctggcccttcccagggccggaaacggcgccag
accagcatgacagatttctaccactccaaacgcaggctgatctgctccaagaggaagccc
taa

DBGET integrated database retrieval system